Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	616.24	1134.95	158.46
Graham Fair Price	33.86	2704.62	2020.51
PEG	-57.51	-0.12	0.29
Price/Book	-4.26	0.21	0.22
Price/Cash Flow	76.66	-18.33	-78.52
Prices/Earnings	53.78	-11.41	-24.69
Price/Sales	-5.97	3.15	3.35
Price/FCF	76.66	-18.33	-78.52
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-0.57	0.15	0.15
Operating Margin	-215.86	-0.04	-0.01
ROA	-107.34	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-107.12
ROIC	< 0.005	< 0.005	-415.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.14	0.05	190.31
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.78	-2.26	191.22
EPS QOQ	0.85	-0.93	8.78
FCF QOQ	< 0.005	-3.16	147980.74
Revenue QOQ	-0.08	0.03	-57.20
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	40.46	48.37	19.54
Days Sales Outstanding (DSO)	63.99	63.58	-0.65
Inventory Turnover	2.22	1.86	-16.35
Debt/Capitalization	0.15	0.13	-13.39
Quick Ratio	0.37	0.40	9.65
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	8962.61	8336.73	-6.98
Cash	214.09	126.00	-41.15
Capex	-9.33	47.61	410.01
Free Cash Flow	-25.46	-97.12	-281.48
Revenue	596.30	564.69	-5.30
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.53	0.59	10.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	63.19	434.94	588.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating